Study of the molecular mechanism of decreased liver synthesis of albumin in inflamation by Moshage, H.J. et al.
Study of the Molecular Mechanism of Decreased Liver Synthesis
of Albumin in Inflammation
H. J. Moshage, J. A. M. Janssen, J. H. Franssen, J. C. M. Hafkenscheid,* and S. H. Yap
Division ofGastrointestinal and Liver Diseases, and *Division of Clinical Chemistry, Department ofMedicine, St. Radboud University
Hospital, Nijmegen, The Netherlands
Abstract
Hypoalbuminemia in inflammatory disorders is not an infrequent
finding. However, little is known about albumin synthesis in these
patients. In the present study we have measured the albumin
synthesis in four patients with inflammatory diseases using the
['4Cjcarbonate technique. Because inflammation causes a de-
creased albumin synthesis and this decreased synthesis could
not be related to a reduced amino acid supply, we have also
examined the possible molecular mechanisms of reduced albumin
synthesis during inflammation using in vivo and in vitro exper-
iments in rats. In rats with turpentine-induced inflammation,
serum albumin concentration and liver albumin mRNA level were
markedly decreased. These changes could not be reproduced by
administration of fibrinogen-, or fibrin-degradation products, or
several hormones, such as corticosteroids, growth hormone, and
adrenaline. However, monocytic products, especially interleukin
1, postulated to be important mediators of the inflammatory re-
sponse, reduced albumin synthesis and liver albumin messenger
RNA content but not total protein synthesis in rats in vivo and
in primary cultures of rat hepatocytes. These findings suggest
that monocytic products play an important role in reduced al-
bumin synthesis during inflammation.
Introduction
Albumin is the most abundant serum protein produced by the
liver. In clinical practice the serum level of albumin continues
to serve as an important marker for the presence, progress, or
improvement of many diseases, even though it is the complex
end result of synthesis, degradation or loss, and distribution be-
tween intra- and extravascular space.
Hypoalbuminemia in patients with inflammatory diseases
such as pneumonia, rheumatoid arthritis, and severe bacterial
infection is not an infrequent finding (1). Although it has been
suggested that increased degradation of albumin is the primary
cause of hypoalbuminemia, little is known about albumin syn-
thesis in such patients. The purpose of this study was to inves-
tigate the albumin synthesis as determined by ['4C]carbonate
technique in patients with inflammatory disorders. Because the
results indicate that an inflammatory reaction could lead to a
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decreased albumin synthesis and no signs of diminished supply
of amino acids to the liver were found as an explanation of the
reduction, we have examined the possible molecular mechanism
ofthe decreased albumin synthesis during the inflammation us-
ing in vivo and in vitro experiments in rats.
Methods
Patients. Age, sex, and diagnosis of the four patients studied are dem-
onstrated in Table I. All patients had a severe or moderate hypoalbu-
minemia. The control group was composed of 20 individuals, 17 males
and 3 females, their ages ranging from 26 to 68 yr. They all had normal
serum albumin level and normal liver "function" tests.
Amino acid analysis. Concentrations of serum amino acids were
estimated using a Beckmann Unichrome (Munchen, FRG) amino acid
analyzer. After precipitation of the proteins (50 mg sulphosalicylic acid
was added to 1 ml serum) and centrifugation, 0.5 ml of the supernatant
was used for analysis. The accuracy of the tryptophan determination on
the amino acid analyser has been tested by adding different amounts of
tryptophan (40-250 MM) to a serum sample that had been dialyzed pre-
viously. After precipitation of the proteins the samples were analyzed
for tryptophan content. The mean recovery of the added tryptophan
was 89.2% (2).
Determination ofplasma volume and albumin synthesis rate. The
plasma volume was determined with '3II-labeled albumin just before the
determination ofthe rate ofalbumin synthesis. '31I-labeled albumin was
prepared according to the method described by McFarlane (3) with slight
modification. The disappearance rate of '31I-labeled albumin was also
determined 7 h after injection of '311-labeled albumin.
Rate of albumin synthesis was measured by the [1'4C]carbonate
method of McFarlane (4), as modified and described by Hafkenscheid
et al. (5).
Patients had a regular hospital diet (- 60 g protein, 60 g fat, and
250 g carbohydrate), all of which was consumed in the period of inves-
tigation. The thyroid gland was blocked with lugol solution, starting 2
d before the determination. In the morning of the investigation, blood
samples were collected for the measurement of serum or blood level of
hemoglobin, hematocrit, albumin, amino acids, creatinine, urea, trans-
aminases, alkaline phosphatase, and leucine amino peptidase. Patients
were not treated with oral antibiotics or chemotherapeutics to reduce
the bacterial urease activity in the intestine. A 50-ml blood sample was
collected 7 h after i.v. injection of 100-200 uCi Na2'4CO3 for the mea-
surement of the specific activity of the ['4C]guanidine group of arginine
in albumin. An additional 8-ml blood sample was obtained at the same
time for the measurement of the specific activity of the endogenously
formed ['4C]urea.
1 d later, 5-10 1ACi t'4C]urea was injected i.v. for the determination
of the disappearance rate of urea (5).
15 ml plasma was saturated to 50% with (NH4)2SO4 for the isolation
of albumin. The precipitate was separated by centrifugation, 30,000 g
for 20 min. The supernatant was adjusted to pH 4.5 by slowly adding I
M HC1, and the albumin thus precipitated was collected by centrifugation.
After redissolving the albumin precipitate in 10 ml ofwater and adjusting
to pH 7.0 with I M NaOH, the entire procedure was repeated. The
albumin fraction, 25 ml, was dialyzed overnight. The purity of the al-
bumin preparation, determined by electrophoresis on cellulose acetate,
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Table I. Age, Sex, Diagnosis, Serum Albumin Concentration, and Liver Enzyme Tests in Four Patients with an Inflammatory Disease
Patient Age Sex Diagnosis Serum albumin ASAT ALAT Alkaline phosphate
yr gMliter U/liter U/liter U/liter
1 69 F Acute pyelocystitis 29.3 4 6 69
2 57 M Periappendicular abscess 29.1 13 28 168
3 23 F Endocarditis lenta 25.8 19 30 54
4 65 M Pulmonary embolism 31.2 6 11 112
Control value 44-55 <15 <15 <120
was 97%. After an adapted dilution the albumin was hydrolyzed, the
arginine was isolated from the hydrolysate, and the specific activity of
the guanidine group of the arginine was determined as described pre-
viously (5).
The calculation of the rate of albumin synthesis can be made using
the precursor-product relationship. The ['4C]arginine produced in the
liver cell from ["4C]carbonate is the common precursor for ['4C]urea
and ['4C]guanidine ofarginine in albumin. Under well-defined conditions
the specific activity ofall products ofa single labeled precursor pool must
be equal to that of the precursor (4). Specific activity of albumin from
tl-tO is then equal to specific activity of synthesized urea from tl-t0:
synthesized albumin (tl-t0) = (sp act of albumin at tO/sp act of urea at
tO) x fractional synthesis rate ofurea X plasma albumin pool. The specific
activity ofalbumin is expressed as the activity ofguanidine C ofarginine
in albumin. The specific activity of serum albumin 7 h after i.v. injection
of 100-200 1ACi Na214CO3 ranged from 1.36 to 2.56 dpm per Mmol ar-
ginine and the specific activity of urea varied from 11.25 to 30.4 dpm/
mmol urea. Because in this study the fractional synthesis of urea was
measured 24 h after injection of Na214CO3 by i.v. administration of 5-
10 11Ci ['4C]urea, it was important to maintain a steady state of urea and
albumin metabolism in this period. Patients were given a constant diet
at the same time in the 2 d of the experiment. Only patients and control
individuals who had serum concentrations of albumin, urea, and urinary
urea excretion at the same level in the 2 d ofexperiments were included
in this study.
Laboratory methods. Transaminases, alkaline phosphatase, and leu-
cine amino peptidase were determined according to routine laboratory
methods.
Animals. Male Wistar rats weighing 180-200 g were used throughout
and maintained on standard Purina chow and water ad lib. For the acute
inflammatory reaction, rats were injected intramuscularly with 1.0 ml
of commercial turpentine.
Preparation ofrat hepatocytes and primary culture. Liver cells were
prepared according to the method of Seglen (6) with some modifications
as described previously (7). All buffers were autoclaved before use and
oxygenated by direct bubbling with oxygen. Collagenase buffer (0.5 mg/
ml) was supplemented with 0.05 mg/ml soybean trypsin inhibi-
tor (7).
Cells were filtered, preincubated, and centrifuged in Ca2" and Mg2"
free Hanks' balanced salt solution (HBSS) containing 2% bovine serum
albumin (BSA). Damaged and nonparenchymal cells were removed. The
cell suspension was then passed through a 100-MM nylon filter and the
viability of the hepatocytes was determined by trypan blue exclusion
tests.
The culture medium was William's medium E supplemented with
5% (vol/vol) fetal calfserum (FCS), 2mM L-glutamine, 20 mU/ml porcine
insulin, dexamethasone as indicated, 2.5 ,g/ml fungizone, 50 Mg/ml gen-
tamycine, and 100 /ml vancomycin. Hepatocytes were seeded at a con-
centration of 175 X 103 cells per cm2 in polystyrene flasks or dishes and
maintained in a humidified atmosphere composed of 95% air and 5%
CO2. The medium was renewed 2-4 h after cell seeding and every 24 h
thereafter.
Incorporation oflabeledprecursor into protein. [3H]Leucine was added
to the cell culture medium (5 MCi/ml). - 50% of leucine present in the
culture medium was radiolabeled (specific activity of [3H]leucine in me-
dium is thus 60 Ci/mmol). At the indicated times, duplicate 75-,41
samples were withdrawn from the medium. 10-id samples were diluted
to 100 Ml in 0.1 N NaOH and 1 ml 10% trichloroacetic acid was added.
Samples were heated for 20 min at 90C and subsequently cooled on
ice for 20 min. Protein precipitates were collected on nitrocellulose filter
discs and counted for radioactivity.
Immunoprecipitation of3H-labeled albumin. Determination of 3H-
labeled albumin in the culture medium was essentially performed as
described previously (8). 25-,gl samples were diluted in 500 JI buffer
containing 10 mM sodium phosphate, pH 7.2, 150 mM NaCl, 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS),
5 mM leucine, 0.1 mM phenylmethylsulfonylfluoride, and 1 mM EDTA
and incubated with 1,000 dpm ['4C]albumin as tracer for recovery, 20
Atg albumin as carrier, and goat-anti-rat albumin y-globulin. After 16
h incubation at 4°C, the mixture was layered over a 200-,ul 10% (wt/wt)
sucrose cushion and centrifuged for 5 min in an Eppendorf centrifuge.
The pellet was washed three times, dissolved in 0.1 NaOH, and precip-
itated with 10% trichloroacetic acid, and collected on nitrocellulose filter
paper discs for counting, using a double-labeling program. ['4C]Albumin
was prepared chemically from the purified protein with ['4C]formaldehyde
by reductive methylation as described by Crane and Miller (9).
DNA determination. Cells were suspended in water and sonicated.
After centrifugation, DNA in supernatant was measured by a fluorometric
technique as described by Kapuscinski and Skoczylas (10).
Preparation of liver and cell RNA. Total postnuclear RNA of liver
tissue was prepared as described by Taylor and Schimke (1 1). Cytoplasmic
RNA from hepatocytes in primary cultures was isolated according to
the following procedure. Cell pellets were homogenized in a buffer con-
taining 50 mM Tris-HCl, pH 7.4, 25 mM NaCl, 5 mM MgCl2, 0.25 M
sucrose and 0.3 mg/ml heparin. After addition of 1/10-vol 10% Triton X-
100 and centrifugation of the particulate material for 10 min at 16,000
g, RNA was extracted by addition of 1/2-vol 0.3 M NaCl, 1.5% SDS, 15
mM EDTA, 30 mM Tris-HCl, pH 9.0, and an equal volume of phenol/
chloroform/isoamylalcohol (50:48:2, vol/vol/vol). When no detectable
interface remained, 2.5 vol cold ethanol was added. RNA was precipitated
overnight at -20°C and isolated by centrifugation at 16,000 g for 20
min at -5°C.
Incorporation of labeled precursor into RNA. 61 mCi/mmol [6-
'4C]orotic acid was added to 3 uCi/ml cell culture medium. At the in-
dicated times, cells of duplicate wells were washed and harvested with
HBSS containing 0.1% Triton X-100. 1 ml of ice-cold 20% trichloroacetic
acid was added to 100-A1 samples and precipitates were collected on
nitrocellulose filter paper discs and counted for radioactivity. Correction
was made for incorporation of [14C]orotic acid into non-RNA by deter-
mining the incorporation in duplo samples treated for 30 min at 90°C
in 10% trichloroacetic acid.
Preparation ofpurified albumin mRNA and 3H-labeled complemen-
tary DNA (cDNA). Purification of mRNA specific for rat albumin and
the synthesis ofthe specific complementary DNA probe from this purified
mRNA have been reported previously (12). Analytical RNA-cDNA hy-
bridization was performed as described previously (13, 14).
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Preparation of monocytic products and specific antibodies against
interleukin I (IL-I).' The monocytic products were prepared by incu-
bation of activated macrophages isolated from peritoneal exudates in-
duced by glycogen in rabbits as described by Ritchie and Fuller (15).
These preparations were endotoxin-free as tested by a Limulus test. The
15-kD-mol wt protein was purified from these monocytic products by
G50-Sephadex chromatography and gel electrophoresis (16). This protein
showed IL- I activity as determined by the thymocyte proliferation assay
(17). Specific antibodies against IL-I were obtained from immunized
goats using this purified 1 5-kD-mol wt protein as immunogen.
For comparison, in some studies we have used commercially available
IL-l obtained from activated human monocytes (ultra-pure human IL-
1, Genzyme Corp., Boston, MA).
Preparation ofpolyA containing RNA. The poly A containing RNA
was prepared from total RNA extracts by oligo (dT) cellulose chroma-
tography (18) as described previously (1 1).
Cell-free protein synthesis and gel electrophoresis. The wheat germ
extract was prepared as described by Marcu and Dudock (19). Radio-
actively labeled product synthesized in vitro was analyzed electropho-
retically on 10% polyacrylamide/Na DodSO4 (SDS) slab gels (20). Dried
slab gels were exposed to x-ray film.
Materials. Na214CO3, ['4C]urea, L-[4,5-3H]leucine (120 Ci/mmol),
[6-'4C]orotic acid (61 mCi/mmol), ['4C]formaldehyde (17.6 mCi/mol),
and [5-3H]dCTP (18.4 Ci/mmol) were obtained from the Radiochemical
Centre, Amersham International, Amersham, UK. ''I as Na'3'I was
from Hoechst A.G., Frankfrt, FRG. Collagenase type I, soybean trypsin
inhibitor, oyster glycogen type III, BSA, heparin from porcine intestinal
mucosa, dithiothreitol, and Hepes were purchased from Sigma Chemical
Co., St. Louis, MO. William's medium E and FCS were from Flow
Laboratories Inc., McLean, VA. Triton X-l00 and SDS were obtained
from BDH Chemicals Ltd., Dagenham, Essex, UK. Ribonuclease-free
sucrose, EDTA, phenol, sodium deoxycholate, salts, and solvents were
purchased from E. Merck, Darmstadt, FRG. Deoxyribonucleoside tri-
phosphates were from Schwarz/Mann, Spring Valley, NY, and oligo(dT)I0
was from Collaborative Research, Inc., Waltham, MA. Avian myelo-
blastosis virus DNA-dependent RNA polymerase was kindly supplied
by Dr. J. W. Beard, National Cancer Institute, Betheida, MD. Nuclease
Sl (Aspergillus oryzae) was purchased from Boehringer Mannheim
GmBH, Mannheim, FRG, and stored at 2.5 10' U/ml in 50% glycerol,
50 mM NaCl, 0.1 mM ZnC12, and 20 mM Tris-HCI, pH 7.5, at -20°C.
Oradexon (dexamethasone disodium phosphate) was obtained from Or-
ganon, The Netherlands.
All glassware was sterilized and solutions were freshly prepared and
autoclaved before use. BSA and soybean trypsin inhibitor were dialyzed
against 0.15 M NaCI and, like all solutions used in the hepatocyte isolation
and culturing, filtered through a 0.22-MM Schleicher & Schuell (Keene,
NH) filter and stored frozen.
Results
Table II demonstrates the plasma volume, intravascular albumin
mass, and albumin synthesis rate of four patients with inflam-
matory disease. All patients had a low serum albumin level and
a decreased intravascular albumin mass. Although the serum
concentrations of amino acids in these patients were normal
(Table III), the albumin synthesis was reduced ranging from
12.6 to 14.3 g/24 h (mean value, 13.4 g/24 h). As compared
with the control value, the result of albumin synthesis in these
patients with inflammatory disease was significantly reduced with
a P value of 0.0036 (Wilcoxon two-sided tested). The liver
"function" tests with the exception of patient No. 2 were all
within normal limits.
For further studies to examine the molecular mechanism of
1. Abbreviation used in this paper: IL-1, interleukin 1.
the reduction of albumin synthesis in inflammatory diseases,
we have used an animal model of inflammation in rats injected
intramuscularly with 1 ml turpentine. Fig. 1 shows the SDS-
polyacrylamide gel electrophoresis of wheat-germ cell-free re-
action products under the direction of poly A containing RNAs
prepared from livers of control rats and animals at intervals
following turpentine injection. Despite the absence of changes
in liver RNA content (data not shown, see also references 13
and 21) there was a decrease of translational activities ofRNAs
into albumin after turpentine administration. Quantitative
analysis using the hybridization kinetics to measure the sequence
content of albumin mRNA in different RNA fractions during
the inflammatory reaction indicates that the concentration of
albumin mRNA sequences in the liver was decreased to 35-
50% of the control value (control value, 7.0% of total poly A
containing RNA). The variability ofthe control measurements,
if repeated in paired animals sham-injected with saline over the
same time course, was 100±9% (mean±SD). The time course
of the changes of serum albumin concentrations and albumin
mRNA levels in the liver is demonstrated in Fig. 2.
These changes of serum albumin concentration and liver
albumin mRNA level could not be reproduced by administration
of fibrinogen or fibrin degradation products and of several hor-
mones such as corticosteroids, growth hormone, and adrenaline
(data not shown). Because monocytic products, especially IL-I
(a 15-kD-mol wt protein in rabbits), have been suggested to play
an important role in the physiological alterations that charac-
terize the acute phase response such as fever, granulocytosis,
and changes in the hepatic synthesis ofthe acute phase-associated
proteins (22, 23), the following in vivo and in vitro experiments
were performed to investigate the influence of these monocytic
products including IL- I on the albumin synthesis.
As shown in Fig. 3, the albumin mRNA concentration in
the liver of rats injected intraperitoneally with monocytic prod-
ucts were decreased and comparable with the findings in rats
treated with turpentine. In addition, concomitant administration
of antisera (1 ml i.p.) against the 15-kD-mol wt protein of
monocytic products partially abolished the effect of turpentine
as well as the effect ofmonocytic products on the serum albumin
level and on albumin mRNA content (68±10% vs. 42±10% of
control value for turpentine-treated rats).
Fig. 4 shows the effect of monocytic products on the
['Hlleucine incorporated into the secreted albumin of primary
cultures of rat hepatocytes. Because the specific activity of
['H]leucine in the culture medium was high, - 50% of leucine
present in the medium was radiolabeled (60 Ci/mmol), and the
fact that ['H]leucine incorporated into secreted total protein was
unchanged and the secreted ['H]fibrinogen was increased, the
reduction of incorporation into the secreted albumin in the
presence of IL-I could not be ascribed to a reduced specific
activity ofleucine tRNA. The [3H]leucine incorporated into the
secreted albumin was therefore the result of decreased albumin
synthesis and secretion. The effects of monocytic products on
the reduction of albumin synthesis and secretion in primary
cultures of rat hepatocytes were more pronounced when 1 uM
dexamethasone was added to the culture medium. Concomitant
with these findings, the albumin mRNA content was also lower
in hepatocytes treated with the monocytic products than in con-
trol hepatocytes (Table IV). Nevertheless, the RNA synthesis of
hepatocytes was not impaired by the addition of monocytic
products in the culture medium (Fig. 5). The rate of albumin
synthesis and secretion in hepatocytes cultured in the presence
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Table II. Plasma Volume, Intravascular Albumin Mass, and Albumin Synthesis Rate ofFour Patients with an Inflammatory Disease
Patient Weight Height Plasma volume Intravascular albumin mass Fractional synthesis rate* Albumin synthesis
kg cm ml g %/day g/24 h mg/kg/h
1 60 160 2,885 84.5 16.5 14.0 9.7
2 66 168 3,048 88.7 16.8 14.3 9.0
3 41.6 165 2,270 58.6 21.6 12.7 12.7
4 71 172 3,300 103 12.2 12.6 7.4
Control value (n = 20; mean±SD) 2,734±410 136±20.7 16.2±4.2 21.9±6.6 13±3.5
* Percent of intravascular albumin mass per day.
of commercially available IL-I was also lower than in control
experiments. Similar to the in vivo findings, addition ofantisera
against the 15-kD-mol wt protein lead to a normalization of
albumin synthesis and secretion in hepatocytes cultured in me-
dium containing monocytic products (430±60% vs. 240±40%
ofcontrol value for hepatocytes cultured for 24 h in the presence
of monocytic products without antiserum; see Fig. 4).
Discussion
Ifalbumin metabolism is in a steady state, the rate of its synthesis
will be equal to the catabolic rate. The estimation of albumin
Table III. Serum Concentrations* ofAmino Acids in Three of
Four Patients with Inflammatory Disease and Hypoalbuminemia
Patient Patient Patient Control
Amino acid 2 3 4 valuet
Essential
Threonine 133 251 98 113±32
Valine 202 389 303 227±42
Methionine 23 53 22 27±9
Isoleucine 80 114 88 84±21
Leucine 129 220 159 141±33
Phenylalanine 88 180 81 74± 15
Lysine 250 177 198 195±47
Tryptophan 33 43 35 45± 14
Total 938 1,191 984 906±213
Nonessential
Serine 119 372 119 125±27
Proline 196 344 182 247±92
Citrulline 20 48 23 37±15
Glycine 188 467 204 259±72
Alanine 322 553 306 403±97
Tyrosine 59 148 82 67±18
Ornithine 59 106 109 101±30
Histidine 128 95 53 88±21
Arginine 129 61 132 123±34
Total 1,220 2,194 1,210 1,450±406
* In umol/liter.
n = 20; mean±SD.
synthesis by the indirect method using radioactive iodine-labeled
albumin has, however, certain limitations because of its long
duration of measurement (- 2-3 wk) and the requirement for
a steady state of albumin metabolism during that period. By
using the ['4C]carbonate method for the determination of al-
bumin synthesis rate, a long period of steady-state metabolism
is not required. The validity of this method for measuring al-
bumin synthesis and the assessment of the possible radiation
hazard involved in the study have been discussed previously (2,
5, 24). Because a steady state ofalbumin metabolism in patients
with acute inflammation cannot be achieved for a long period,
albumin synthesis under these circumstances cannot be deter-
mined by the indirect method of radioactive iodine-labeled al-
bumin.
In our present paper we report the albumin synthesis as de-
termined by [14C]carbonate method in four patients with in-
flammatory disorders and severe hypoalbuminemia. Only pa-
tients and control subjects who had unchanged concentrations
of serum albumin, urea, and urinary urea excretion at the same
level in the period of experiments were included for this study.
Although the albumin degradation was not determined in these
patients, the measurements showed a decreased intravascular
albumin mass and a reduction of albumin synthesis. A reduced
rate ofalbumin synthesis can be the result ofmalnutrition, mal-
digestion, and/or malabsorption, or a severe diffuse liver disease
68kD_- -- Figure 1. Autoradio-
graph of SDS-polyacryl-
* g Ad amide gel electrophore-
45kD sis of wheat germ trans-
j 3_ w lation products under
the direction of liver
mRNAs isolated from
control rats and animals
25kD after turpentine injec-
I 5^ ^ tion. Lane 1, [14CJ-la-
_
At <*beled marker proteins:
albumin, 68-kD mol wt;
1 2 3 4 5 ovalbumin, 45-kD mol
wt; and chymotrypsin,
25-kD mol wt. Lane 2, translation products directed by poly A-con-
taining mRNA isolated from rat liver 24 h after injection of I ml i.m.
turpentine. Lane 3, as indicated in lane 2, 48 h after turpentine injec-
tion. Lane 4, as indicated in lane 2, 72 h after injection. Lane 5, trans-
lation products directed by poly A-containing mRNA isolated from
control rat liver. Arrow denotes position of albumin on gel.
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Figure 2. Time course of the changes in serum albumin concentra-
tions and albumin mRNA levels in the liver during inflammation in-
duced by administration of 1 ml i.m. turpentine. Relative change in
albumin mRNA levels was determined from hybridization data by
comparison of the Rotj,2 value of control poly A-containing RNA
with the ROtI/2 values obtained from poly A-containing RNAs of rat
livers at various time intervals after turpentine treatment. Serum albu
min concentration was measured according to the routine laboratory
method, with a control value of 30.1±2.0 mg/ml. (Rot is the product
of initial RNA concentration in mole nucleotides per liter and time ir
seconds, given that A260 of 1.0 corresponds to 40 jig RNA per ml.
ROt112 is Rot value at 50% hybridization).
(1). Because clinical evidence of liver disease and intestinal al
normalities was absent in our patients and there were norm
serum concentrations of amino acids, the reduction of albumi
synthesis in our patients was most likely not due to a diminishe
supply of amino acids to the liver or the result ofa primary liv
disease.
To examine the possible molecular mechanism ofdecrease
albumin synthesis in the liver during inflammation, we ha'
therefore studied the liver content of albumin messenger RN
in rats and its translational activities in vitro using a wheat ger
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Figure 4. Secretion of albumin in primary cultures of rat hepatocytes
into culture medium in absence of dexamethasone (upper panel) and
in presence of 50 nM (middle panel) and 1 AuM dexamethasone (lower
panel). Results were obtained from determination of [3H]leucine in-
b- corporated into immunoprecipitable albumin per microgram cellular
al DNA and expressed as percentage of value obtained 6 h after adding
in [3H]leucine in the absence of IL- l. IL- l was added as crude leukocytic
d extract (200 Ag per ml culture medium). Results are the means±SD of
er four experiments. Hepatocytes were cultured for 24 h with test sub-
stances before adding [3H]leucine.
,d
ve
[A
m cell-free translational system. The results indicate that during
the inflammatory reaction after tissue injury, the decreased level
of serum albumin is associated with a reduced concentration of
albumin mRNA in the liver (Figs. 1 and 2). Because an inflam-
matory reaction does not lead to a decreased level of total liver
RNA and the fibrinogen mRNA content and the fibrinogen syn-
thesis were increased under this condition (13, 21), the decreased
content of liver albumin mRNA is most likely regulated specif-
ically by a different molecular process or mechanism.
Hypoalbuminemia and a decreased albumin synthesis during
the acute phase response have been described previously, and
Table IV. Relative Level ofAlbumin mRNA in Hepatocytes
Culturedfor 48 h in Presence of I AsM
Dexamethasone With and Without Monocytic Products
Figure 3. Relative levels of albumin mRNA in rat liver after treatment
with saline (1 ml; i.p.), crude leucocytic extract (1-3 mg, 12 h after i.p.
administration), and turpentine (1 ml i.m., 12 and 24 h after adminis-
tration). Values are expressed as percentages of controls (mean±SD, n
= 4) and were obtained from hybridization data as described in Fig. 2.
Relative level of
Culture medium hepatocytic albumin mRNA
Without IL-I 100%
With 200 ug/mI IL-i 49±10%
Mean±SD of four experiments.
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Figure 5. Incorporation of [6-'4C]orotic acid into total RNA of hepa-
tocytes in primary cultures in absence (open circles) and presence
(closed circles) of IL- I in culture medium. At the indicated times, cells
were harvested and processed as described in Methods. IL- was added
as crude leukocytic extract (200 ,g per ml culture medium). Results
are the means±SD of four experiments. Hepatocytes were cultured for
24 h with test substances before adding ['4Cjorotic acid.
albumin has been indicated as a negative acute-phase reactant
(21, 23). However, the precise molecular mechanism for the
reduction of albumin synthesis has still not been completely
elucidated. Nevertheless, a number offactors have been suggested
to play an important role in the regulation of liver synthesis of
acute phase proteins, such as hormones, fibrinogen-, or fibrin
degradation products, and monocytic products, including IL- 1
(15, 25, 26). From our previous studies (7, 25, 26) and other
investigations (data not shown) we have demonstrated that cor-
ticosteroids, growth hormone, insulin, adrenaline, fibrinogen,
and fibrin degradation products cannot be implicated in mod-
ulating the hepatic synthesis of albumin during the acute-phase
response, because administration of these hormones in vivo in
rats or in vitro in experiments using primary cultures of rat
hepatocytes did not lead to a reduced synthesis of albumin, al-
though in other studies, the fibrinogen synthesis in rats could
be stimulated by in vivo administration of fibrinogen or fibrin
degradation products (26).
In our present study, we demonstrate that monocytic prod-
ucts reduce the hepatocytic albumin mRNA content in vivo and
in vitro. Because the orotic acid incorporation into total RNA
was unchanged (Fig. 5) and there was a stable RNA content,
the level of albumin mRNA must be affected specifically by the
monocytic products and not because of a decreased RNA syn-
thesis or level in general. In fact the level of mRNAs of acute-
phase protein was increased under this condition (data not
shown). The effect of monocytic products on the albumin syn-
thesis and secretion of hepatocytes in vitro is augmented in the
presence of 1 MM dexamethasone. The role of dexamethasone
on albumin secretion and the content of albumin mRNA in
hepatocytes in vitro has been discussed previously (7). The lack
of a significant decrease of serum albumin level in rats after
administration of monocytic products (data not shown) is due
to the masking effect of a relatively long half-life of serum al-
bumin in the relatively short duration of experiments and the
absence of protein loss, as was the case in turpentine injection
due to exudation. Nevertheless, reduced albumin synthesis and
secretion by hepatocytes can be clearly observed in primary cul-
tures after the addition of monocytic products (Fig. 4). In con-
trast, the synthesis and secretion of total protein in vitro is not
affected by the monocytic products (data not shown). Although
in these experiments we did not utilize a specific purified product
of macrophages, the results of experiments in vivo in rats after
turpentine injection or administration of monocytic products
in vivo and in vitro indicate that reduced albumin synthesis
under these circumstances can be partially abolished by the ad-
ministration of specific anti-sera against the 1 5-kD-mol wt pro-
tein of monocytic products. In addition, similar findings have
also been obtained in experiments using commercially available
purified IL-1. Therefore, we can conclude from these findings,
that hypoalbuminemia during the inflammatory reaction can
be partially ascribed to a specifically decreased synthesis of al-
bumin in the liver as the result of monocytic (macrophagic)
products, including IL-1.
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